Effect of Mepolizumab in Severe Bilateral Nasal Polyps

NCT03085797 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

414

Enrollment

INDUSTRY

Sponsor class

Conditions

Nasal Polyps

Interventions

DRUG: Mepolizumab
DRUG: Placebo
DRUG: Mometasone furoate

Sponsor

GlaxoSmithKline

Collaborators

[object Object]
[object Object]